Detecting tissue-specific alternative splicing and disease-associated aberrant splicing of the PTCH gene with exon

Kazuaki Nagao1, Naoyuki Togawa, Katsunori Fujii

  • 1Department of Genetics, National Research Institute for Child Health and Development, Tokyo, Japan.

Human Molecular Genetics
|October 6, 2005
PubMed

Insights

Researchers discovered novel PTCH gene splicing variations, including a brain-specific exon, using oligonucleotide microarrays. This method also identified disease-associated splicing defects in nevoid basal cell carcinoma syndrome (NBCCS) patients.

Area of Science:

  • Genetics
  • Molecular Biology
  • Bioinformatics

Background:

  • Mutations in the patched (PTCH) gene are linked to nevoid basal cell carcinoma syndrome (NBCCS), a disorder associated with developmental anomalies and increased cancer risk.
  • Alternative splicing (AS) of PTCH mRNA can generate diverse isoforms, but comprehensive analysis and disease relevance are not fully understood.

Purpose of the Study:

  • To identify and characterize novel PTCH mRNA isoforms generated by alternative splicing.
  • To investigate the tissue-specific regulation of PTCH alternative splicing.
  • To develop and validate a microarray-based method for detecting aberrant PTCH splicing in genetic disorders like NBCCS.

Main Methods:

  • Design and utilization of custom oligonucleotide microarrays with exon, exon-exon junction, and intron probes for comprehensive PTCH splicing analysis.
  • Normalization of probe intensities based on total PTCH expression and probe sensitivity.
  • Validation of microarray findings using reverse transcription polymerase chain reaction (RT-PCR).

Main Results:

  • Identification of numerous PTCH mRNA isoforms, including a novel exon (12b), primarily generated through alternative splicing.
  • Exon 12b demonstrated specific expression in brain and heart tissues, particularly the cerebellum.
  • The developed microarray technique successfully detected disease-associated aberrant splicing events in NBCCS patients, linked to mutations disrupting splice donor sites.

Conclusions:

  • Oligonucleotide microarrays with exon junction probes are effective for studying tissue-specific alternative splicing.
  • This approach provides a powerful tool for investigating aberrant splicing in genetic disorders, aiding in the diagnosis and understanding of diseases like NBCCS.